 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
The Journal of Neuroscience, February 15, 2000, 20(4):1616-1621
The Role of CNS Glucagon-Like Peptide-1 (7-36) Amide Receptors in Mediating the Visceral Illness Effects of Lithium Chloride
Randy J. Seeley1, Kathleen Blake1, Paul A. Rushing1, Stephen Benoit1, John Eng3, Stephen C. Woods1, and David D'Alessio2 1 Department of Psychiatry and 2 Division of Endocrinology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0559, and 3 Department of Medicine, Bronx VA Medical Center, New York, New York 10468
Peripheral administration of large doses of lithium chloride (LiCl) to rats causes a spectrum of effects that are consistent with visceral illness. LiCl reduces food intake, decreases salt ingestion after sodium depletion, induces pica, and produces robust conditioned taste aversions. Because some of the effects of peripheral LiCl are mimicked by centrally administered glucagon-like peptide-1 (7-36) amide (GLP-1), we hypothesized that this peptide is involved in the neural pathways by which LiCl causes visceral illness. To test this hypothesis, we pretreated rats with a selective and potent GLP-1 receptor antagonist given directly into the third ventricle via an indwelling cannula before administration of peripheral LiCl. The GLP-1 receptor antagonist completely blocked the effect of LiCl to reduce food intake, induce pica, and produce a conditioned taste aversion. The same dose of GLP-1 receptor antagonist did not reverse the LiCl-induced reduction in NaCl intake. The data indicate a role for GLP-1 receptors in the CNS pathway that mediates some of the effects of visceral illness.
Key words: emesis; nucleus of the solitary tract; anorexia; cachexia; food intake; pica; conditioned taste aversion; paraventricular nucleus; central nucleus of the amygdala; nausea
Copyright © 2000 Society for Neuroscience 0270-6474/00/2041616-06$05.00/0
This article has been cited by other articles:
J. G. Barrera, D. A. D'Alessio, D. J. Drucker, S. C. Woods, and R. J. Seeley
Differences in the Central Anorectic Effects of Glucagon-Like Peptide-1 and Exendin-4 in Rats
Diabetes, December 1, 2009; 58(12): 2820 - 2827.
[Abstract] [Full Text] [PDF]
C. C. Horn, B. C. De Jonghe, K. Matyas, and R. Norgren
Chemotherapy-induced kaolin intake is increased by lesion of the lateral parabrachial nucleus of the rat
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2009; 297(5): R1375 - R1382.
[Abstract] [Full Text] [PDF]
R. Abu-Hamdah, A. Rabiee, G. S. Meneilly, R. P. Shannon, D. K. Andersen, and D. Elahi
The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 1843 - 1852.
[Abstract] [Full Text] [PDF]
R. Nogueiras, D. Perez-Tilve, C. Veyrat-Durebex, D. A. Morgan, L. Varela, W. G. Haynes, J. T. Patterson, E. Disse, P. T. Pfluger, M. Lopez, et al.
Direct Control of Peripheral Lipid Deposition by CNS GLP-1 Receptor Signaling Is Mediated by the Sympathetic Nervous System and Blunted in Diet-Induced Obesity
J. Neurosci., May 6, 2009; 29(18): 5916 - 5925.
[Abstract] [Full Text] [PDF]
P. J Larsen
Mechanisms behind GLP-1 induced weight loss
The British Journal of Diabetes & Vascular Disease, November 1, 2008; 8(2_suppl): S34 - S41.
[Abstract] [PDF]
S. C. Woods and D. A. D'Alessio
Central Control of Body Weight and Appetite
J. Clin. Endocrinol. Metab., November 1, 2008; 93(11_Supplement_1): s37 - s50.
[Abstract] [Full Text] [PDF]
D. D'Alessio
Intestinal Hormones and Regulation of Satiety: The Case for CCK, GLP-1, PYY, and Apo A-IV
JPEN J Parenter Enteral Nutr, September 1, 2008; 32(5): 567 - 568.
[Abstract] [Full Text] [PDF]
R. Faipoux, D. Tome, S. Gougis, N. Darcel, and G. Fromentin
Proteins Activate Satiety-Related Neuronal Pathways in the Brainstem and Hypothalamus of Rats
J. Nutr., June 1, 2008; 138(6): 1172 - 1178.
[Abstract] [Full Text] [PDF]
T. P. Vahl, M. Tauchi, T. S. Durler, E. E. Elfers, T. M. Fernandes, R. D. Bitner, K. S. Ellis, S. C. Woods, R. J. Seeley, J. P. Herman, et al.
Glucagon-Like Peptide-1 (GLP-1) Receptors Expressed on Nerve Terminals in the Portal Vein Mediate the Effects of Endogenous GLP-1 on Glucose Tolerance in Rats
Endocrinology, October 1, 2007; 148(10): 4965 - 4973.
[Abstract] [Full Text] [PDF]
L. Rinaman and V. Dzmura
Experimental dissociation of neural circuits underlying conditioned avoidance and hypophagic responses to lithium chloride
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1495 - R1503.
[Abstract] [Full Text] [PDF]
K. G. Kumar, A. C. Poole, B. York, J. Volaufova, A. Zuberi, and B. K. S. Richards
Quantitative trait loci for carbohydrate and total energy intake on mouse chromosome 17: congenic strain confirmation and candidate gene analyses (Glo1, Glp1r)
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R207 - R216.
[Abstract] [Full Text] [PDF]
D. L. Williams, D. G. Baskin, and M. W. Schwartz
Leptin Regulation of the Anorexic Response to Glucagon-Like Peptide-1 Receptor Stimulation
Diabetes, December 1, 2006; 55(12): 3387 - 3393.
[Abstract] [Full Text] [PDF]
O. Chaudhri, C. Small, and S. Bloom
Gastrointestinal hormones regulating appetite
Phil Trans R Soc B, July 29, 2006; 361(1471): 1187 - 1209.
[Abstract] [Full Text] [PDF]
F. Yi, P. L. Brubaker, and T. Jin
TCF-4 Mediates Cell Type-specific Regulation of Proglucagon Gene Expression by {beta}-Catenin and Glycogen Synthase Kinase-3{beta}
J. Biol. Chem., January 14, 2005; 280(2): 1457 - 1464.
[Abstract] [Full Text] [PDF]
J. L. Lachey, D. A. D'Alessio, L. Rinaman, J. K. Elmquist, D. J. Drucker, and R. J. Seeley
The Role of Central Glucagon-Like Peptide-1 in Mediating the Effects of Visceral Illness: Differential Effects in Rats and Mice
Endocrinology, January 1, 2005; 146(1): 458 - 462.
[Abstract] [Full Text] [PDF]
L. Rinaman
Hindbrain contributions to anorexia
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1035 - R1036.
[Full Text] [PDF]
H. J. Grill, J. S. Carmody, L. Amanda Sadacca, D. L. Williams, and J. M. Kaplan
Attenuation of lipopolysaccharide anorexia by antagonism of caudal brain stem but not forebrain GLP-1-R
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1190 - R1193.
[Abstract] [Full Text] [PDF]
C. Acuna-Goycolea and A. van den Pol
Glucagon-Like Peptide 1 Excites Hypocretin/Orexin Neurons by Direct and Indirect Mechanisms: Implications for Viscera-Mediated Arousal
J. Neurosci., September 15, 2004; 24(37): 8141 - 8152.
[Abstract] [Full Text] [PDF]
J. A. Lovshin, Q. Huang, R. Seaberg, P. L. Brubaker, and D. J. Drucker
Extrahypothalamic Expression of the Glucagon-Like Peptide-2 Receptor Is Coupled to Reduction of Glutamate-Induced Cell Death in Cultured Hippocampal Cells
Endocrinology, July 1, 2004; 145(7): 3495 - 3506.
[Abstract] [Full Text] [PDF]
D. A. D'Alessio and T. P. Vahl
Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes
Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E882 - E890.
[Abstract] [Full Text] [PDF]
D. J. Drucker
Enhancing Incretin Action for the Treatment of Type 2 Diabetes
Diabetes Care, October 1, 2003; 26(10): 2929 - 2940.
[Abstract] [Full Text] [PDF]
N. Vrang, C. B. Phifer, M. M. Corkern, and H.-R. Berthoud
Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R470 - R478.
[Abstract] [Full Text] [PDF]
K. P. Kinzig, D. A. D'Alessio, J. P. Herman, R. R. Sakai, T. P. Vahl, H. F. Figueiredo, E. K. Murphy, and R. J. Seeley
CNS Glucagon-Like Peptide-1 Receptors Mediate Endocrine and Anxiety Responses to Interoceptive and Psychogenic Stressors
J. Neurosci., July 16, 2003; 23(15): 6163 - 6170.
[Abstract] [Full Text] [PDF]
R. Gros, X. You, L. L. Baggio, M. G. Kabir, A. M. Sadi, I. N. Mungrue, T. G. Parker, Q. Huang, D. J. Drucker, and M. Husain
Cardiac Function in Mice Lacking the Glucagon-Like Peptide-1 Receptor
Endocrinology, June 1, 2003; 144(6): 2242 - 2252.
[Abstract] [Full Text] [PDF]
H. Yamamoto, T. Kishi, C. E. Lee, B. J. Choi, H. Fang, A. N. Hollenberg, D. J. Drucker, and J. K. Elmquist
Glucagon-Like Peptide-1-Responsive Catecholamine Neurons in the Area Postrema Link Peripheral Glucagon-Like Peptide-1 with Central Autonomic Control Sites
J. Neurosci., April 1, 2003; 23(7): 2939 - 2946.
[Abstract] [Full Text] [PDF]
K. Inoue, G. R. Valdez, T. M. Reyes, L. E. Reinhardt, A. Tabarin, J. Rivier, W. W. Vale, P. E. Sawchenko, G. F. Koob, and E. P. Zorrilla
Human Urocortin II, a Selective Agonist for the Type 2 Corticotropin-Releasing Factor Receptor, Decreases Feeding and Drinking in the Rat
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 385 - 393.
[Abstract] [Full Text]
Z. Ni, Y. Anini, X. Fang, G. Mills, P. L Brubaker, and T. Jin
Transcriptional Activation of the Proglucagon Gene by Lithium and beta -Catenin in Intestinal Endocrine L Cells
J. Biol. Chem., January 3, 2003; 278(2): 1380 - 1387.
[Abstract] [Full Text] [PDF]
K. P. Kinzig, D. A. D'Alessio, and R. J. Seeley
The Diverse Roles of Specific GLP-1 Receptors in the Control of Food Intake and the Response to Visceral Illness
J. Neurosci., December 1, 2002; 22(23): 10470 - 10476.
[Abstract] [Full Text] [PDF]
L. Rinaman and E. E. Rothe
GLP-1 receptor signaling contributes to anorexigenic effect of centrally administered oxytocin in rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R99 - R106.
[Abstract] [Full Text] [PDF]
C. B. Lawrence, K. L. J. Ellacott, and S. M. Luckman
PRL-Releasing Peptide Reduces Food Intake and May Mediate Satiety Signaling
Endocrinology, February 1, 2002; 143(2): 360 - 367.
[Abstract] [Full Text] [PDF]
P. J. Larsen, C. Fledelius, L. B. Knudsen, and M. Tang-Christensen
Systemic Administration of the Long-Acting GLP-1 Derivative NN2211 Induces Lasting and Reversible Weight Loss in Both Normal and Obese Rats
Diabetes, November 1, 2001; 50(11): 2530 - 2539.
[Abstract] [Full Text] [PDF]
I. Billig, B. J. Yates, and L. Rinaman
Plasma hormone levels and central c-Fos expression in ferrets after systemic administration of cholecystokinin
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1243 - R1255.
[Abstract] [Full Text] [PDF]
D. J. Drucker
Minireview: The Glucagon-Like Peptides
Endocrinology, February 1, 2001; 142(2): 521 - 527.
[Abstract] [Full Text] [PDF]
J. Lovshin, J. Estall, B. Yusta, T. J. Brown, and D. J. Drucker
Glucagon-like Peptide (GLP)-2 Action in the Murine Central Nervous System Is Enhanced by Elimination of GLP-1 Receptor Signaling
J. Biol. Chem., June 8, 2001; 276(24): 21489 - 21499.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|